The presented package image matches the product design registered with the Ukrainian regulatory authorities.
If you have noticed any differences, please call us at +380 44 490 75 22
Dosage form
Powder for injection intramuscular adm. intratracheal adm. intracavernous.
Active ingredient
1 vial contains streptomycin sulfate sterile recalculated to streptomycin 0.5 g or 1.0 g.
Indications
Treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs. Patients who were treated earlier, it is advisable to prescribe medication after laboratory detection of sensitivity to drug patient isolated mycobacteria. Infectious-inflammatory processes of different localization, caused by gram-positive and gram-negative microorganisms sensitive to the drug: pneumonia caused by klebsiella, endocarditis, plague, tularemia, brucellosis.
If you have information about any adverse effects or other drug-related problems, please fill in the form